Categories: News

RiverMeadow Expands Global Reach with Launch in AWS Asia Pacific (Taipei) Region

LOS GATOS, Calif., June 10, 2025 /PRNewswire/ — RiverMeadow Software Inc., a leader in workload mobility automation, is excited to announce the availability of its Workload Mobility Platform in the AWS Asia Pacific (Taipei) Region, marking another key milestone in the continued strategic global expansion alongside AWS’s extensive infrastructure. This expansion supports RiverMeadow’s mission to provide seamless, scalable, and secure migration capabilities to customers worldwide.

- Advertisement -

The AWS Asia Pacific (Taipei) Region provides customers with greater flexibility to run workloads and securely store data in Taiwan, improving performance with lower latency. The new AWS Region supports developers, startups, entrepreneurs, public and private sector organizations, as well as industries such as education, entertainment, financial services, healthcare, and more – giving greater choice for running their applications and serving end users from AWS data centers located in Taiwan, enabling customers to retain their content onshore with confidence.

- Advertisement -

RiverMeadow’s commitment extends across Asia, with tailored support now available in multiple key AWS regions, including Taipei, Osaka, Malaysia, and Taiwan. This continued growth reflects the dedication to deliver end-to-end Workload Mobility Solutions wherever organizations need to operate.

- Advertisement -

“The momentum in Southeast Asia, particularly in Taipei, is undeniable,” said Jim Jordan, CEO of RiverMeadow. “Our platform is uniquely positioned to help customers take full advantage of the new AWS region by delivering automation, speed, and security in their migration journeys”

- Advertisement -

Why Migrate to AWS Taipei with RiverMeadow?

- Advertisement -
  • Rapid Time to Value – Begin migrating workloads in as little as 30 minutes, accelerating ROI from day one.
  • Solution Flexibility – Migrate complex environments across hosted and private platforms with full VM and OS flexibility.
  • Scalability – Enable rapid migrations at scale through a decoupled data transfer architecture.
  • Integrated Automation – Shorten migration timelines with integrated and custom automation.
  • Derisked Migrations – Minimize source impact and accelerate acceptance testing.
  • Cost Reduction – Reduce operational expenses by eliminating technical debt.
  • AWS’s ISV funding program available in region to reduce overall migration costs.

Discover the advantages of AWS Taiwan by leveraging RiverMeadow’s trusted Workload Mobility Platform. Whether you’re expanding into Asia, looking to mitigate rising costs from Broadcom pricing changes or simply transitioning away from current hosting/cloud providers,  RiverMeadow can help.

- Advertisement -

About RiverMeadow
RiverMeadow provides multi-cloud and hybrid-cloud workload mobility solutions that automate the migration and modernization of existing workloads to any cloud or virtualized environment. With a proven track record across complex enterprise transformations, RiverMeadow is the trusted partner for organizations navigating modernization at scale.

- Advertisement -

Media Contact
Flor de Maria Vazquez – Director – Sales Operations
RiverMeadow Software Inc.
Email: flor@rivermeadow.com 

- Advertisement -

Logo – https://mma.prnewswire.com/media/694644/logo_stacked_color_Logo.jpg

- Advertisement -

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

7 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

7 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

7 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

7 hours ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

7 hours ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

7 hours ago